
News|Articles|January 1, 2002
Acute migraine therapy: Triptan quantity limit maintains total health care savings 1 year out
Prime Therapeutics, St. Paul, MN-Do quantity limits on abortive migraine medications (ie, triptans) and educational efforts to increase the use of prophylactic therapy reduce total health care costs over the long term?
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Insights from the AMCP Nexus 2025 Meeting
2
The Shift in Star Ratings That Health Plans Can't Ignore
3
Clinical and Economic Impact of OAB Symptoms in Men Receiving Pharmacological Treatment for BPH
4
MHE Week in Review – HPV Vaccine Still Effective, Dry Eye Disease Lacks Effective Treatments and More
5

















































